495 related articles for article (PubMed ID: 15804710)
41. [Antineutrophil cytoplasmic antibodies (ANCA): clinico-pathologic correlations iin a series of 82 cases].
Calvo Romero JM; Romero Requena J; Arévalo Lorido JC; Ramos Salado JL; Doblaré Castellano E; Vargas Pérez ML; Bureo Dacal P; Pérez Miranda M
An Med Interna; 2002 Jan; 19(1):7-10. PubMed ID: 11989089
[TBL] [Abstract][Full Text] [Related]
42. Antigen-specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease.
Trevisin M; Pollock W; Dimech W; Melny J; Paspaliaris B; Gillis D; Wong R; Savige J
Am J Clin Pathol; 2008 Jan; 129(1):42-53. PubMed ID: 18089488
[TBL] [Abstract][Full Text] [Related]
43. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
44. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
46. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
48. Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
Kawakami T; Takeuchi S; Arimura Y; Soma Y
Br J Dermatol; 2012 Jun; 166(6):1206-12. PubMed ID: 22309950
[TBL] [Abstract][Full Text] [Related]
49. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
[TBL] [Abstract][Full Text] [Related]
50. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.
Savige J; Dimech W; Fritzler M; Goeken J; Hagen EC; Jennette JC; McEvoy R; Pusey C; Pollock W; Trevisin M; Wiik A; Wong R;
Am J Clin Pathol; 2003 Sep; 120(3):312-8. PubMed ID: 14502794
[TBL] [Abstract][Full Text] [Related]
51. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
Csernok E; Gross WL
Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
[TBL] [Abstract][Full Text] [Related]
52. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
Wüthrich RP
Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
[TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
Takizawa M
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
55. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
56. Pauci-immune crescentic glomerulonephritis.
Gupta RK
Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
[TBL] [Abstract][Full Text] [Related]
57. Laboratory diagnostics in vasculitis patients.
Wiik A
Isr Med Assoc J; 2001 Apr; 3(4):275-7. PubMed ID: 11344841
[TBL] [Abstract][Full Text] [Related]
58. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
59. Antineutrophil cytoplasmic autoantibodies (ANCA)--markers in diagnosis and monitoring systemic vasculitides.
Cristea A; Badea T; Bodizs G; Olinic N
Rom J Intern Med; 1995; 33(1-2):37-46. PubMed ID: 8535351
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
